docetaxel

Is There A Clinical Benefit Derived From Using Low Dose Prednisone With First Line Docetaxel Treatment In Men With Castrate Resistant Prostate Cancer?

There have been some randomized studies that have shown that when prednisone is used in combination with docetaxel (chemotherapy) there is an improved survival in men who have metastatic castration-resistant prostate cancer (mCRPC). To add to our understanding of the possible clinical value of this combination of drugs some researchers have retrospectively evaluated whether the [...]

By Malecare|2020-02-04T11:38:36-05:00September 24th, 2015|Advanced Prostate Cancer, Chemotherapy, Combination Therapy, docetaxel, edema, neutropenia, Research, Uncategorized|0 Comments

Our New Therapies and the Development of Cross Resistance to these Drugs

Men with metastatic castrate resistant prostate cancer (mCRPC) have become fortunate over the last few years as there we now have a number of new drugs available which can extend our life and can also have some palliative effects. However, as we have more treatments being approved, we find that we are faced with a [...]

By Malecare|2020-02-04T11:35:47-05:00September 3rd, 2015|Advanced Prostate Cancer, Cabazitaxel, Chemo Therapy, Chemotherapy, Combination Therapy, Cross Resistance, docetaxel, Drugs & Treatments, Hormone Therapy, Inhibitors, Jevtana, Repurposing Drugs, Sequencing Therapies, taxanes, taxotere, Uncategorized, Xtandi, Zytiga|0 Comments

Chemotherapy in Very Elderly Men with Metastatic Castration-Resistant Prostate Cancer

Clinical trials for treatment of men with advanced prostate cancer often don’t include men who are considered very elderly (aged over 80 years). So, even if we know that a treatment is tolerable and effective in the average man, we can not assume that it would also be in the very elderly, especially in reference [...]

By Malecare|2020-02-04T11:40:52-05:00August 25th, 2015|Advanced Prostate Cancer, Chemotherapy, docetaxel, Drugs & Treatments, Research, taxotere, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

Are You Having Trouble Getting Early Access To Chemotherapy?

During last year’s American Society of Clinical Oncologists (ASCO) Annual Meeting, data was released from the STAMPEDE trial which should change clinical practice around the world. The trial results showed that newly diagnosed men with very aggressive prostate cancer that was still hormone therapy naive (no ADT) would have a very significant survival advantage by [...]

By Malecare|2015-07-21T18:35:53-04:00July 21st, 2015|ADT, Advanced Prostate Cancer, Advocacy, ASCO, Chemotherapy, Clinical Trials & Research, docetaxel, Drugs & Treatments, Hormone Therapy, Politics of Cancer, Survival, taxotere, Uncategorized, United Kingdom - England, Northern Ireland, Scotland & Wales|0 Comments

Evaluating The Side Effects Of Docetaxel (Taxotere) vs Cabazitaxel (Jevtana)

Many men express great hesitation to move to chemotherapy with both docetaxel (taxotere) and cabazitaxel (Jevtana) because of the side effects which can include alopecia (hair loss), nail changes, neuropathy, and dysgeusia (a distortion of the sense of taste). A group of researchers hypothesized that the adverse side effects (AE) of these two chemotherapy drugs, [...]

By Malecare|2020-02-04T11:37:16-05:00May 26th, 2015|Advanced Prostate Cancer, Cabazitaxel, Chemotherapy, docetaxel, Jevtana, peripheral neuropathy, Side Effects, taxotere, Uncategorized|1 Comment

Make Sure You Receive the Correct IV Treatment, Injection and Dosage

It is vital that you take an active role in making sure that you are going to receive the correct IV treatment and injections. Mistakes do happen, protect yourself. Make sure that you personally double check to confirm you're receiving the correct treatment. Don't sit back and rely on another person, errors do occur and [...]

By Malecare|2017-10-19T10:47:23-04:00May 1st, 2015|Advanced Prostate Cancer, bisphosphonates, Cabazitaxel, Chemo Therapy, denosumab - Xgeva, docetaxel, Drugs & Treatments, General Information, Uncategorized, Zometa|0 Comments

Using Circulating Tumor Cells To Evaluate Chemotherapy Efficacy Leading To Improved Clinical Decision Making

Today most doctors rely on their personal evaluation or objective response criteria (OR) of a man to know when docetaxel chemotherapy has stopped working. The earlier this determination can be accurately made the quicker an alternative treatment can e put into place. Personal evaluations without any validated tools are unreliable and never consistent among doctors. [...]

By Malecare|2020-02-04T11:37:08-05:00April 23rd, 2015|Advanced Prostate Cancer, CTCs, docetaxel, prognostic tools, Research, Uncategorized|0 Comments

Is Cabazitaxel Before Docetaxel The Future Way To Go? *

Chemotherapy for prostate cancer is still limited to just two drugs, docetaxel (Taxotere) and cabazitaxel (Jevtana). Both of these chemotherapy drugs are taxanes, but they seem to be very different in their mode of action. A study published online in Clinical Cancer Research, indicates that cabazitaxel might be more effective for some men than docetaxel. [...]

By Malecare|2020-02-04T11:15:45-05:00February 18th, 2015|Advanced Prostate Cancer, Cabazitaxel, docetaxel, Drugs & Treatments, Jevtana, Research, taxanes, taxotere, Uncategorized, Understanding APC|0 Comments